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Abstract
Glucokinase (GK), a glucose sensor, maintains plasma glucose homeostasis via phosphorylation of glucose and is a potential
therapeutic target for treating maturity-onset diabetes of the young (MODY) and persistent hyperinsulinemic hypoglycemia
of infancy (PHHI). To characterize the catalytic mechanism of glucose phosphorylation by GK, we combined molecular
modeling, molecular dynamics (MD) simulations, quantum mechanics/molecular mechanics (QM/MM) calculations,
experimental mutagenesis and enzymatic kinetic analysis on both wild-type and mutated GK. Our three-dimensional
(3D) model of the GK-Mg
2+-ATP-glucose (GMAG) complex, is in agreement with a large number of mutagenesis data, and
elucidates atomic information of the catalytic site in GK for glucose phosphorylation. A 10-ns MD simulation of the GMAG
complex revealed that Lys169 plays a dominant role in glucose phosphorylation. This prediction was verified by
experimental mutagenesis of GK (K169A) and enzymatic kinetic analyses of glucose phosphorylation. QM/MM calculations
were further used to study the role of Lys169 in the catalytic mechanism of the glucose phosphorylation and we found that
Lys169 enhances the binding of GK with both ATP and glucose by serving as a bridge between ATP and glucose. More
importantly, Lys169 directly participates in the glucose phosphorylation as a general acid catalyst. Our findings provide
mechanistic details of glucose phorphorylation catalyzed by GK, and are important for understanding the pathogenic
mechanism of MODY.
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Introduction
Glucokinase (GK) is a glycolic enzyme that catalyzes the
phosphorylation of glucose to glucose-6-phosphate in the first step
of glycolysis. Expressed in the liver, pancreas, brain and gut, GK
plays a key role in maintaining glucose homeostasis through
regulation of glucose-dependent insulin secretion in pancreatic
cells, and glucose uptake and storage in the liver [1–3]. Clinical
evidences have shown that GK might be an important therapeutic
target for treating metabolic diseases such as maturity-onset
diabetes of the young (MODY) and persistent hyperinsulinemic
hypoglycemia of infancy (PHHI) [4–7].
Although GK belongs to the hexokinase family [8], GK is
distinctive from other hexokinases because of its relatively low
glucose affinity in the range of blood-glucose levels and its positive
cooperative kinetics. These properties allow GK to rapidly
respond to changes in glucose concentrations under physiological
conditions, and thereby function as a glucose sensor [9]. Various
studies have demonstrated that GK is a monomeric enzyme whose
allosteric mechanism is different from those found in other
extensively studied oligomeric allosteric enzymes [10–14]. Com-
parison of the crystal structures of GK in closed state (active state)
and super-open state (inactive state) shows that GK may undergo
a global conformational change between these two states, and such
a conformational change may be responsible for the special
allosteric characteristics of GK [15]. Recently, we used molecular
dynamics simulation method to show that the global conforma-
tional transition pathway between the two states of GK includes
three intermediate steps, identified by free energy scanning of
snapshots throughout the pathway. The computational predictions
were verified by mutagenesis and enzymatic kinetic analysis [16].
These studies gave the underlying principle of the enzymatic
mechanism of GK and provided the explanations for the sigmoidal
kinetic effect and the mnemonical mechanism for the cooperativity
of GK with respect to glucose phosphorylation [17].
Recently, data for over 100 different mutations in the GK
genes, potentially contributing to the development of an autosomal
dominant form of type 2 diabetes, have been collected [18].
Among the data, some mutations in the MODY phenotype were
found to be linked to alterations in both GK kinetics and
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the most critical information for understanding the relation
between the mutations in the MODY gene and GK regulation
activity. This fundamental question remains unanswered, howev-
er, due to the lack of an accurate structural model for the complex
of GK with ATP, glucose and Mg
2+ (GK-Mg
2+-ATP-glucose
complex). In particular, an important residue in the binding
pocket, Lys169, can undergo mutation (K169N) in MODY [20]
and its functional role remains unknown.
Here, we report a study of the catalytic mechanism of GK by
combining molecular modeling, molecular dynamics (MD)
simulations, quantum mechanics/molecular mechanics (QM/
MM) calculations, experimental mutagenesis and enzymatic
kinetic analysis. The atomic structure of the glucose phosphory-
lation catalyzed by GK in aqueous solution was studied using
protein substrate conformations obtained from the MD simula-
tion. The simulation results are in agreement with the recent
findings of mutagenesis experiments and related kinetic studies.
MD simulations further revealed that Lys169 may play an
essential role in both ligand binding and GK catalytic process.
The computational prediction was verified by additional experi-
mental mutagenesis and kinetic analysis. Based on these results, we
propose an atomistic catalytic mechanism of GK for glucose
phosphorylation using QM/MM calculations. Findings from this
work provide a better understanding of the enzymatic mechanism
of GK, and also a potential explanation of the pathogenic
mechanism of MODY caused by the mutation in GK.
Results
The main goal of this study is to investigate the catalytic process
of human GK by using computational methods in conjunction
with enzymatic assay. Such a study, however, needs an accurate
structural model for the whole catalytic environment of GK, i.e.
the three-dimensional (3D) structure of the complex of GK with
ATP, glucose and Mg
2+ (GK-Mg
2+-ATP-glucose complex,
designated as GMAG complex hereinafter). Accordingly, a 3D
structural model of GMAG complex was constructed based on the
crystal structures of GK and several other hexokinases by using
molecular modeling. Following this, the dynamic conformation
change of the catalytic site of GK was investigated by using MD
simulations. Furthermore, the modeling and simulation results
were validated using mutagenesis and enzymatic kinetic assays.
Encouraged by the compatible results from theoretical prediction
and experiments, we explored the GK catalytic mechanism for the
glucose phosphorylation based on a stable conformation of
GMAG complex derived from the MD simulations by using
quantum mechanics/molecular mechanics (QM/MM) method.
3D Model of the GK-Mg
2+-ATP-glucose (GMAG) Complex
The crystal structure of human GK had not been available until
2004 due to the high flexibility of the protein [21]. Moreover, it is
easy for ATP to transfer its terminal phosphate to glucose in situ,
making it difficult to gain accurate structural information of the
catalytic environment of glucose inside GK, which plays a critical
role in understanding the catalytic and regulation mechanisms of
GK. Several models for GK catalytic environment have been
published [22–27]. However, these models were built using
homology modeling based on the X-ray crystal structure of
human hexokinase type I [28,29]. Although human hexokinase
type I is homologous to GK with sequence identity of ,55%, its
three-dimensional (3D) structure is different, especially around the
ATP binding pocket, as indicated by the structural superposition
of the crystal structures of these two enzyme (Figure S1). The
reliability of these GK catalytic models is therefore questionable.
On the basis of the crystal structures of GK, now available, we
built up a structural model for the GMAG complex (see Materials
and Method section for detail). This model is more accurate than the
previous models, and has also been validated by further MD and
QM/MM calculations, as well as mutagenesis experiments and
enzymatic assays (see discussion below).
Structurally, GK is composed of a large domain and a small
domain; the channel-shaped active site for phosphorylation is
located in the deep cleft between these two domains, as shown in
Figures 1A and 1B. The Mg
2+ ion and ATP (Mg
2+-ATP) are
predicted to bind to the left portion of the active site cleft,
interacting with both domains [22–24]. The Mg
2+-ATP binding
site is formed by residues 78–83, 169, 225–228, 295–298, 331–
336, 410–413, and 415–417 (Figure 1C). Meanwhile, the glucose
resides in a small pocket composed of residues 80–81, 151–154,
168–169, 204–207, 225–232, 254–259, 287 and 290 (Figure 1D).
Our 3D model of GMAG complex reveals that GK provides
a favorable microenvironment for the phosphorylation of glucose.
Several important hydrogen bonds between ligands (ATP, Mg
2+
and glucose) and GK are observed in our model (Table S1), which
are in agreement with a large number of mutagenesis analysis data
[20,30–34]. The c-phosphate of ATP is close to the –O
6H group
of glucose with electrostatic interaction, indicating that the c-
phosphate is about to be transferred to glucose.
To study the stability of the reaction environment, a 10-ns
molecular dynamics (MD) simulation was performed on the
GMAG complex. The time evolutions of the weighted Root-Mean
Square Deviations (wRMSD) for the atoms of GK, ATP and
glucose from their initial positions (t=0 ps) were monitored. The
result indicates that all the reaction components are relatively
stable except for the rotation of the –O
6H group which causes an
increase in wRMSD of glucose by 0.3 A ˚ at 1 ns (Figure S2). The
H-bond network amongst GK, ATP and glucose also reflects the
stability of the phosphorylation environment. These H-bonds were
mostly maintained during the 10-ns MD simulation as indicated
by their occupancies (Table S1).
Under the restriction of GK, ATP, Mg
2+ and glucose form
a highly advantageous configuration for the biochemical reaction
(Figure 2). Mg
2+ ion in the binding site octahedrally coordinates
with the oxygen atoms of two water molecules, O
b1,O
c1 and O
c3
oxygen atoms of ATP and the O
d2 atom of Asp205. Nine H-bonds
are formed between ATP and residues of GK, i.e. the N
1 atom of
adenine with the –O
cH group of Ser336, the O
a2 atom of ATP
with the –NH groups of Thr82 and Asn83, the O
a1 atom of ATP
with the –O
cH group of Ser411, the O
a3 and O
b3 atoms of ATP
with the –O
cH Thr228, the O
c2 atom of ATP with the –NH
group of Gly229, and the O
c1 and O
c2 atoms of ATP with the
–N
fH
+
3 group of Lys169 (Figure 2 and Table S1). These H-bonds
lead the ATP to adopt a conformation appropriate to coordinate
with the Mg
2+ ion and to interact with glucose. On the other side,
glucose forms seven H-bonds with the GK residues, viz. the –O
4H
group of glucose with the N
d1 atom of Asn204 and the O
d1 atom
of Asp205, the –O
3H group of glucose with the O
e1 and O
e2 atoms
of Glu256 and the –NH group of Phe152, the –O
1H group of
glucose with the O
e1 atom of Glu290, the O
5 atom of glucose with
the –N
fH
+
3 group of Lys169 (Figure 2 and Table S1). Most
importantly, the –O
6H group of glucose directly hydrogen bonds
to the O
c2 atom of ATP, producing the requisite complex for
glucose phosphorylation. Residues detected in the naturally
occurring mutations (e.g. K169N, T228M, E256K, S336L, and
S411F) from MODY families [20,30–32] are involved in the H-
bond network for the binding of GK with glucose and ATP.
Extensive work confirmed that S336L mutation decreased both
Lys169 Plays a Key Role in GK
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enzyme [33]. Several other site-directed mutants, including
N204A, E256A and E290A, have been shown to alter GK’s
enzymatic kinetics by decreasing the binding affinity of glucose
and lowering Vmax in the catalytic process [31,34]. These
mutagenesis and enzymatic results demonstrate that our 3D
model of GMAG complex is reasonable.
Importance of Lys169 in the Phosphorylation of Glucose
and Mutation Validation
Among the conserved residues hydrogen bonding to ATP and
glucose, Lys169 is of special interest because its cationic end,
–N
fH
+
3, bridges ATP and glucose together through H-bonds,
placing the c-phosphorus (P
c) atom only 3.3 A ˚ far way from the
–O
6H group of glucose (Figure 2). This implies that Lys169 might
play an important role in the phosphorylation of glucose.
Additionally, it was reported that Lys169Asn (K169N) is one of
the naturally occurring mutations in the GCK gene associated with
familial mild fasting hyperglycemia [20]. The K169N mutant was
also shown to experience a partial loss of glucose binding [30].
To address the biological function of Lys169, we constructed
a 3D structural model for the GK K169A mutant (GKK169A)i n
complex with ATP-Mg
2+ and glucose, and two additional MD
simulations of the ATP-Mg
2+-GKK169A and glucose-GKK169A
complexes were conducted. Binding free energies of ATP and
glucose with wild-type GK and GKK169A (Table S2) were then
calculated using the MM-PBSA method encoded in AMBER
(Version 8.0). Both ATP and glucose are able to bind tightly to the
wild-type GK with calculated binding free energies of
218.6764.59 and 244.0663.94 kcal/mol, respectively. While
neither ATP nor glucose can bind with GKK169A.
The MD simulations and binding free energy calculations
indicate that Lys169 may dominate the binding of both ATP and
glucose, and hence the K169A mutant possibly loses the catalytic
function for the phosphorylation of glucose. To verify this
Figure 1. The structural model of GMAG complex. (A) 2D topological structure plot of GMAG. (B) 3D structure of GMAG. (C) Important
interactions between ATP and GK. (D) Important interactions between glucose and GK. ATP, Mg
2+, glucose and important residues in GK are
displayed in stick and labeled. Black dashed lines represent hydrogen bonds or salt bridges.
doi:10.1371/journal.pone.0006304.g001
Lys169 Plays a Key Role in GK
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6304conclusion, a bioassay on the K169A mutant was performed and
result is shown in Table 1. The kinetic assay indicates that K169A is
indeed an inactivating mutation; its enzymatic activity is completely
abolished. Far-UV CD spectra and fluorescence emission spectra
results demonstrated that the K169A mutant had well-defined
secondary structures; thereby we canexcludethe possibility that this
mutation may have caused GK to undergo misfolding (Figures S3,
S4, S5). Thus, the MD prediction, regarding the importance of
Lys169 to the binding of ATP and glucose with GK and to the
catalytic activity of GK as well was validated.
Lys169 Acts as a General Acid Catalyst
To further figure out the role of Lys169 in enzymatic catalysis,
the reaction mechanism of glucose phosphorylation inside the
active site of GK was investigated by using the QM/MM
approach. The system for QM/MM simulation was constructed
based on the snapshot at 2500 ps of the MD trajectory. The QM
region was composed of Mg
2+, water molecules coordinating with
Mg
2+, important groups of ATP, glucose, Lys169 and Asp205; the
remainder of GK was included in the MM region (Figure S6). The
partitioning scheme for QM and MM regions is described in the
Materials and Methods section and Figure S6. We designate this
structure as reagent system. For the reagent system, the initial
coordination configuration of Mg
2+ with waters, ATP and glucose
and the hydrogen bonding pattern amongst ATP, glucose, Lys169
and Asp205 have been described above (Figure 2). ONIOM,
a QM/MM method encoded in Gaussion03 [35], was used for all
the QM/MM calculations (Figure 3 and 4).
The QM/MM optimized geometry of the reagent system
showed that Mg
2+ octahedrally coordinates with the O
b1and O
c1
Figure 2. A close view of the configuration of glucose phosphorylation in the environment of GK active site. The structural model was
constructed based on the snapshot at 2500 ps isolated from the 10-ns MD trajectory. W1 and W2 represent water molecules. ATP, Mg
2+, glucose and
important residues in GK are displayed in stick and labeled. Black dashed lines represent hydrogen bonds or salt bridges. Atomic numbering of ATP
and glucose is displayed in the up-left panel.
doi:10.1371/journal.pone.0006304.g002
Table 1. Kinetic analysis of GK and GKK169A.
Mutants Protein conc. (mg/ml) Vmax_Glucose (mM/min/mg) S_Glucose 0.5 (mM) Km_ATP (mM) nH
LGK2-WT 2.24 3966.1361107.69 11.6460.83 0.3060.01 1.4060.12
K169A mutant 2.24 N/A N/A N/A N/A
Data are means6SEM for wild-type hLGK2 and hLGK2 mutants. The results are means of kinetic analyses of three independent experiments of wild-type hLGK2 and
hLGK2 mutants. nH is the Hill number.
doi:10.1371/journal.pone.0006304.t001
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d2 atom of Asp205 and three oxygen atoms
from three water molecules (Figure 3). The major difference of the
optimized structure for the reaction center from the initial
structure obtained by MD simulation is that one water molecule
substituted the O
c3 atom to coordinate with the Mg
2+ ion. QM
optimization resulted in important structural changes viz. one
proton of the –N
fH
+
3 group of Lys169 transferred to the O
c3
atom, and the resulting –N
fH2 group formed a H-bond with the
new water molecule coordinating with the Mg
2+ ion; on the other
hand, the –O
6H group of glucose adjusted its direction to point
toward the O
d1 atom of Asp205, forming two strong H-bonds with
the O
d1 and O
d2 atoms of Asp205. This structural reorganization
made the –O
6H group more propitious to attack the P
c atom of
ATP, implying that Lys169 might act as an acid catalyst and
Asp205 as a base catalyst in the phosphorylation of glucose. Thus,
we propose a mechanism for the glucose phosphorylation
catalyzed by GK as Scheme 1 (Figure 5). Along this reaction
path, the energies of the reagent (R), transition state (TS), and
immediate product (P) were determined by two-dimensional QM/
MM potential energy surface by defining the distances of
R(O
b3_P
c) and R(P
c_O
6) as the reaction coordinates (Figure 3).
In the optimized reagent, R(O
b3_P
c)=1.69 A ˚ and R(P
c_O
6)=
3.39 A ˚; and in the optimized immediate product, the O
b3_P
c
bond is broken and the P
c_O
6 is formed, R(P
c_O
6)=1.71 A ˚.
The calculated potential energy barrier of Scheme 1 is DE
?=
18.3 kcal/mol.
The structure of the transition state (TS) in Scheme 1 was
determined by adiabatic mapping at the QM/MM level (Figure 3).
In the TS, R(O
b3_P
c)=2.1 A ˚ and R(P
c_O
6)=2.0 A ˚, and the c-
phosphate (–P
cO3) is turned to be in a plane. This structure clearly
illustrates that the P
c_O
6 bond is partially formed and the O
b3_P
c
bond is partially broken. The overall reaction is calculated to be
exothermic by DE=222.1 kcal/mol.
To further address the catalytic role of Lys169, we investigated
the reaction mechanism of glucose phosphorylation catalyzed by
the GKK169A mutant employing the QM/MM method. Com-
pared with the optimized structure of GK reagent system, the
major difference for the ATP-GKK169A-glucose reaction center is
that the –O
6H group of glucose doesn’t form H-bond with either
O
d1 or O
d2 atom of Asp205, but forms a strong H-bond with the
Figure 3. The potential energy surface of the reaction pathway corresponding to Scheme 1. The structures displayed at the top of the
potential surface are the QM/MM optimized structures of the reagent (R), transition state (TS), and immediate product (P). For clarity, only the
structures around the reaction center have been shown.
doi:10.1371/journal.pone.0006304.g003
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c3 atom of ATP. This optimized structure implies an alternative
path for the glucose phosphorylation as Scheme 2 (Figure 6): the
proton of the –O
6H group transfers to the O
c3 atom of ATP while
the O
6 atom attacks the P
c atom of ATP, and at the same time the
O
b3_P
c bond is broken. According to this reaction path, we
obtained the structures and energies of reagent (R), transition state
(TS), and immediate product (P) by calculating the two-
dimensional QM/MM potential energy surface; the distances of
R(O
b3_P
c) and R(P
c_O
6) were defined as the reaction coordinates.
The result is shown in Figure 4. For the TS, R(O
b3_P
c)=2.1 A ˚
and R(P
c_O
6)=1.9 A ˚. Remarkably, the calculated potential
energy barrier of this reaction path is DE
?=32.1 kcal/mol,
which is ,14 kcal/mol higher than that of the reaction catalyzed
by the wild-type GK. This result indicates that the phosphoryla-
tion of glucose could not occur without the assistance of Lys169.
Discussion
As mentioned above, GK is a key enzyme that phosphorylates
glucose and triggers glucose utilization and metabolism. As an
attractive drug target for discovering anti-diabetes drug, the
importance of this enzyme has been appreciated. However, the
unique catalytic mechanism of GK still remains unclear [17,18].
Several mutants of GK with the MODY phenotype have been
identified recently; in particular, it was found that K169N is
a naturally occurring mutation (K169N) in MODY [20]. In this
study, we have investigated the phosphorylation mechanism of
glucose catalyzed by GK, and revealed that Lys169 is a crucial
residue for glucose phosphorylation.
By using molecular modeling and simulation methods, we
constructed a 3D structural model for the complex of GK with
ATP, glucose and Mg
2+ (GMAG complex). This structural model is
more reliable than previously published models [22–27,36] because
it was constructed based on the crystal structures of human GK. In
particular, this model provides a more realistic reaction environ-
ment for the phosphorylation of glucose. The validity of the
structural model of GMAG was confirmed by the agreement
between the available experimental mutagenesis and enzymatic
data for GK and the important interactions of GK with ATP,
glucose and Mg
2+ identified through computation [20,30–34].
Both ATP and glucose interact with the residues lining the
binding pocket of GK through H-bonds (Figure 2). Among these
Figure 4. The potential energy surface of the reaction pathway corresponding to Scheme 2. The structures displayed at the top of the
potential surface are the QM/MM optimized structures of the reagent (R), transition state (TS), and immediate product (P). For clarity, only the
structures around the reaction center have been shown.
doi:10.1371/journal.pone.0006304.g004
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with both ATP and glucose. This indicates that Lys169 contributes
to the binding of GK with either ATP or glucose or both.
Computational simulations demonstrated that both ATP and
glucose are able to bind to the wild-type GK, and neither ATP nor
glucose can bind to the GKK169A mutant (Table S2). Indeed, the
experimental mutagenesis and enzymatic kinetic assay validated
the computational prediction, i.e. the mutant of K169A could not
bind to ATP and glucose and its enzymatic activity is completely
lost (Table 1).
The QM/MM calculations on the mechanisms of glucose
phosphorylation catalyzed by both GK and GKK169A mutant
further revealed the role of Lys169 in catalysis. During the
phosphorylation process of glucose, in addition to enhancing the
binding of ATP and glucose with GK, Lys169 also acts as
a general acid catalyst, providing a proton to protonate the O
c3
atom of ATP; at the same time Asp205 acts as a general base
catalyst, extracting the proton from the –O
6H group of glucose
(Scheme 1). On the other hand, ATP and glucose bind to the
GKK169A mutant with a different model than with the wild-type
GK (Figures 3 and 4), whereby the phosphorylation of glucose
adopts a different mechanism (Scheme 2). The QM/MM
calculated activation energy of Scheme 2 is ,14 kcal/mol higher
than that of Scheme 1. This suggests that the GKK169A mutant has
significantly reduced catalytic activity than its wild-type form. The
calculated result is in good agreement with our mutagenesis data
(Table 1). Moreover, the QM/MM result also indicates that
Asp205 of GK loses its function as a general base catalyst in the
glucose phosphorylation when Lys169 is absent (Figure 4).
The agreement between computation and experimental results
validates the essential role of Lys169 in the phosphorylation of
glucose. In summary, Lys169 plays at least three functional roles in
the metabolism of glucose: (1) it enhances the binding of GK to
both ATP and glucose; (2) it bridges ATP and glucose together;
Figure 5. Reaction mechanism of glucose phosphorylation catalyzed by the wild-type GK.
doi:10.1371/journal.pone.0006304.g005
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glucose phosphorylation. These results are important for un-
derstanding the catalytic mechanism of GK and the cause of the
pathogenic mechanism of MODY due to the GK muta-
tion[17,18]. Obviously, asparagine cannot act as a general acid
catalyst because its side chain is incapable of providing a proton to
ATP, as shown in Figure S7. Our study thus provides an
explanation of why the catalytic activity of the mutant GK
(K169N) in the MODY is lower than that of the wild-type GK.
Materials and Methods
Structural Model
On the basis of crystal structures GK (the active human GK
with glucose, PDB entry 1V4S) and two hexokinases (human brain
hexokinase complexed with glucose and phosphate, PDB entry
1HKC, and monomeric hexokinase I complexed with ADP, PDB
entry 1DGK) as templates, the whole structural model of GMAG
complex (GK-Mg
2+-ATP-glucose complex) was constructed by
using a heuristic approach. The crystal structure of GK-glucose
complex (1V4S) was used as a basal structure. The ATP
conformation was generated according to the structure of ADP
in the crystal structure of 1DGK, and the coordination
configuration of Mg
2+ with ATP (Mg
2+-ATP) was constructed
based on the coordination state of Mg
2+ in the crystal structure of
1HKC. Then the Mg
2+-ATP was ‘‘grafted’’ to the binding pocket
of GK, and the primary position of Mg
2+-ATP was decided
through structural superimposition for the crystal structures of the
three enzymes using the Homology module of Insight2005
(Accelrys, San Diego, CA). For the initial structure of the GMAG
complex, residues within a radius of 6.5 A ˚ around the binding site
were optimized by energy minimization using the AMBER force
Figure 6. Reaction mechanism of glucose phosphorylation catalyzed by the GKK169A mutant.
doi:10.1371/journal.pone.0006304.g006
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following parameters: a distance-dependent dielectric function,
non-bonded cutoff of 8 A ˚, Amber charges for the protein,
Gastieger-Hu ¨ckel charges for ATP and glucose. The structure
was minimized by simplex method first, followed by Powell
method to an energy gradient,0.05 kcal/(mol?A ˚). The structural
model of GK169AMAG and GK169NMAG complex were simply
constructed by replacing Lys169 with Ala and Asn respectively,
followed by minimization using the same protocol as in the
structural optimization for the model of GMAG.
Molecular Dynamics Simulation and Binding Free Energy
Calculation
MD simulations were performed on the GMAG and GK169A-
MAG complexes. Before simulations, each complex was put into
a suitably sized box, of which the minimal distance from the
protein to the box wall was 15 A ˚. Then the box was solvated with
the SPC (Simple Point Charge) water model [37]. Each complex/
water system was submitted to energy minimization. Afterwards,
counterions were added to the system to provide a neutral
simulation system. The whole system was subsequently minimized
again. The charges of the atoms of ATP and glucose were
calculated by using the RESP method [38] encoded in the
AMBER suite of programs [39] at the level of RHF/6-31G*.
Covalent and non-bonded parameters for the ligand atoms were
assigned, by analogy or through interpolation, from those already
present in the AMBER force field [40].
MD simulations were carried out using the AMBER package
(Version 8.0) with constant temperature, constant pressure (NPT),
and periodic boundary conditions. The AMBER Parm99 force
field [40] was applied for the proteins. The Particle Mesh Ewald
method [41] was used to calculate the long-range electrostatics
interactions. The non-bonded cutoff was set to 12.0 A ˚, and the
non-bonded pairs were updated every 25 steps. The SHAKE
method [42] was applied to constrain all covalent bonds involving
hydrogen atoms. Each simulation was coupled to a 300 K thermal
bath at 1.0 atm of pressure (1 atm=101.3 kPa) by applying the
algorithm of Berendsen et al. [43]. The temperature and pressure
coupling parameters were set as 1 ps. An integration step of 2 fs
was set up for the MD simulations.
On the basis of the equilibrated dynamic trajectory, the binding
free energy of each system (GMAG, GKK169A-Glucose and
GKK169A-Mg
2+-ATP) was calculated by using the MM-PBSA
method encoded in the AMBER 8.0 program. Coordinates from
the trajectory were used every 20 ps, and the MM-PBSA
calculation was performed on each of them using the AMBER
8.0 program. For each snapshot collected during the simulations,
binding free energy (DGbinding) was calculated using Eq. (1):
DGbinding~DGcomplex{ DGligandzDGreceptor

ð1Þ
where DGcomplex, DGligand and DGreceptor are the free energies of
the complex and two components of interaction. Each free energy
term in Eq. (1) in AMBER 8.0 was calculated with the absolute
free energy in gas phase (Egas), the solvation free energy
(DGsolvation) and the entropy term (TDS) using Eq. (2):
DG~EgaszDGsolvation{TDS ð2Þ
Egas is the sum of the internal strain energy (Eint), van der Waals
energy (Evdw) and electrostatic energy (Eelectrostatic) (Eq. (3)). Eint is
the energy associated with vibrations of covalent bonds and bond
angles, rotation of single bond torsional angles (Eq. (4)).
Egas~EintzEvdwzEelectrostatic ð3Þ
Eint~EbondzEanglezEtorsion ð4Þ
The solvation free energy, DGsolvation, is approximated as the sum
of the polar contribution (GPB) and nonpolar contribution
(Gnonpolar) using a continuum representation of the solvent:
DGsolvation~GPBzGnonpolar ð5Þ
The polar contribution (GPB) to the solvation energy was
calculated using PB model in sander module. The nonpolar
contributions (Gnonpolar) were estimated using a simple equation:
Gnonpolar=c6SASA+b (kcal/mol). SASA is the solvent-accessible
surface area estimated using the MSMS algorithm with probe
radius of 1.4 A ˚. The surface tension proportionality constant c and
the free energy of nonpolar solvation for a point solute b were set
to 0.00542 kcal/(mol A ˚ 2) and 0.092 kcal/mol, respectively.
The entropy calculation is extremely time-consuming for large
systems. In addition, the main aim of calculating the binding free
energy was to address the influence of mutations to the binding
affinity. Site-directed mutation may not result in dramatic
conformational changes for the protein and it was assumed that
entropy contributes little to the relative binding free energy for the
binding of mutant in comparison with the wild-type protein.
Therefore, in this study, DGbinding (without term of -TDS) was
estimated to address the mutation effect to of the binding free
energy.
QM/MM Calculation
QM/MM calculations were performed by using a two-layered
ONIOM method encoded in the Gaussian03 program [35]. The
ONIOM method is a hybrid computational method developed by
Morokuma and coworkers that allows different levels of theory to
be applied to different parts of a molecular system [44–52]. In the
two-layered ONIOM method, the molecular system under study is
divided into an inner layer and an outer layer. The inner layer
consists of the most critical elements of the system, and the rest of
the system comprises the outer layer. In the terminology of
Morokuma and co-workers, the full system is called ‘‘real’’ and is
treated with a low level of theory. The inner layer is termed
‘‘model’’ and is treated with both the low level of theory and a high
level of theory. The total ONIOM energy EONIOM is given as
following:
EONIOM~E high,model ðÞ zE low,real ðÞ {E low,model ðÞ ð 6Þ
where E(high, model) is the energy of the inner layer (plus the link
atoms) at the high level of theory, E(low, real) is the energy of the
entire system at the low level of ONIOM theory, and E(low, model) is
the energy of the model system at the low level of theory. Thus, the
ONIOM method allows one to perform a high-level calculation on
just a small, critical part of the molecular system and incorporate
the effects of the surrounding elements at a lower level of theory to
yield a consistent energy expression on the full system.
The minimized structure optimized using the AMBER Parm99
force field was further optimized at the ONIOM (B3LYP/6-31G*:
Amber) level. The quantum mechanics (QM) region includes the b,
c-phosphate group offullyunprotonatedATP,fourwatermolecules
including two coordinated water molecules, Mg
2+ ion, the
hydroxymethyl group (–CH2–O
6H) of glucose, the methyleneam-
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fH
+
3) of Lys169 and the anionic
carboxymethyl group (–CH2–COO
2) of Asp205 for a total of 40
atoms (Figure S6). The QM region was calculated by using the
density functional theory with the B3LYP exchange-correlation
functional and 6–31G* basis set. The remainder of the system (MM
region) wastreatedby usingthe AMBER Parm99force field. A total
of 7,147 atoms were included for the QM/MM calculations by
using the ONIOM module as implemented in Gaussian 03. The
electrostatic interactions between the QM and MM regions were
calculated by using the electronic embedding method, which treats
the polarization of the QM region by the MM region with scaled
partial atomic charges of MM atoms, and the response of QM
region with Merz-Singh-Kollman scheme for charge fitting so as to
produce the changing partial charges of the QM atoms. The charge
for the QM region was 21, and the charge for the MM was 1,
therefore the total system remained neutral.
Expression, Purification and Kinetic Analysis on GK and Its
K169A Mutant
Escherichia coli (E. coli) host strain M15 was purchased from
Qiagen (Valencia, CA). All chemicals were of reagent grade or
ultra-pure quality, and commercially available. Human liver
glucokinase isoform 2 (hLGK2) DNA sequence was prepared by
total gene synthesis method (Sangon, Shanghai, China).
Human liver GK isoform 2 (hLGK2) plasmid was digested with
restriction endonucleases BamHI and SalI (NEB), and cloned into
a prokaryotic expression vector pQE-30 (Qiagen) to produce the
recombinant plasmid pQE-30-hLGK2, containing a N-terminal
six-histidine tag to facilitate purification. The recombinant clone
pQE-30-hLGK2 was confirmed by sequencing. The pQE-30-
hLGK2 mutant K169A was constructed by PCR (polymerase
chain reaction)-based site-directed mutagenesis using pQE-30-
hLGK2 as template. To make the single-amino-acid-change
mutants, the following primer (F: forward; R: reverse) was used
during PCR:
K169A: F: 59 CCTTCTCAACTGGACCgcgGGCTTCA
AGGCC39
R: 59 GGCCTTGAAGCCcgcGGTCCAGTTGAGAAGG39
Detailed procedures referred to QuikChangeH Site-Directed
Mutagenesis Kit (Stratagene) instruction manual. The mutant
clones pQE-30-hLGK2 K169A was also confirmed by sequencing.
Expression and purification of the recombinant protein was
performed according to His-Bind Kits (Novagen, San Diego, CA).
The recombinant clones pQE-30-hLGK2 and pQE-30-hLGK2
K169A were separately transformed into E. coli strain M15 that
grew in LB media supplemented with 100 mg/mL ampicillin and
50 mg/mL kanamycin at 37 uC. Expressions of pQE-30-hLGK2
was induced by 0.3 mM IPTG (Isopropyl-b-D-thiogalactopyrano-
side) when the OD600 reached 0.6 at 25 uC for an additional 16–
20 h. The hLGK2 cells were harvested by centrifugation and
suspended in Buffer A (20 mM Tris-HCl, pH 8.0, 500 mM NaCl,
10 mM imidazole), stored at 280 uC after centrifugation until use.
Packed cells were suspended in Buffer A plus 1 mM PMSF
(Phenylmethanesulfonylfluoride), after sonication treatment on ice,
the mixture was centrifuged to yield a clear supernatant, which
was loaded onto a column with Ni-NTA resin (Qiagen) pre-
equilibrated in Buffer A (20 mM Tris-HCl, pH 8.0, 500 mM
NaCl, 10 mM imidazole). The column was washed with 8–10
column volumes of Buffer B (20 mM Tris-HCl, pH 8.0, 500 mM
NaCl, 20 mM imidazole) and eluted with Buffer C (20 mM Tris-
HCl, pH 8.0, 500 mM NaCl, 150 mM imidazole), then the
soluble hLGK2 fractions were pooled separately and dialyzed
against Buffer D (25 mM HEPES, pH 7.1, 25 mM KCl, 2 mM
MgCl2, 1 mM DTT) to remove imidazole. The hLGK2 protein
was thus concentrated by ultrafiltration with Amicon centrifugal
filter device to appropriate concentration. All procedures including
purification, dialysis and concentration were performed at 4 uC.
Protein concentration was determined by Bradford assay using
bovine serum albumin (BSA) as standard. The expressions,
purifications and the subsequent procedures of hLGK2 mutant
K169A protein were the same as that of hLGK2 protein.
The recombinant proteins of hLGK2 and hLGK2 mutant
K169A was subjected to kinetic analysis (Vmax,K m-ATP,S 0.5 and
nH) according to the published procedure reported by Grimsby et
al. [53]. The assay solution contained 25 mM HEPES (pH 7.1),
25 mM KCl, 2 mM MgCl2, 1 mM ATP (0.01 mM, 0.03 mM,
0.06 mM, 0.10 mM, 0.20 mM, 0.30 mM, 0.40 mM, 0.50 mM,
0.60 mM, 0.80 mM, 1.0 mM and 2.0 mM in Km-ATP assay),
1 mM DTT, 1 mM NAD, 0.1% BSA, 5 U/ml glucose-6-
phosphate dehydrogenase from Leuconostoc mesenteroides,5 m M
glucose (0.1 mM, 0.4 mM, 1.0 mM, 2.0 mM, 5.0 mM,
10.0 mM, 20.0 mM, 64.0 mM, 100.0 mM, 200 mM, 300 mM
and 400 mM in S0.5 assay) and 18.7 ug/ml hLGK2 or hLGK2
mutants fusion protein in a total volume of 0.12 ml. All assays at
25 uC were conducted in a 96-well plate system (Benchmark
TM
Plus Microplate Spectrophotometer) by measuring the increase in
absorbance at 340 nm.
CD spectra of hLGK2 WT and hLGK2 mutant proteins
CD spectra of hLGK2 WT and K169A mutant proteins were
recorded on a Jasco-810 spectropolarimeter equipped with
a thermal controller. The protein sample was prepared in 20 mM
NaH2PO4,p H7 . 1 ,a t2 5 uC with protein concentration of 5 mM.
Far-UV CD spectra from 190 to 250 nm were collected with 1 nm
bandwidth using a 0.1 cm path length cuvette and normalized by
subtracting the base line recorded for the buffer under identical
conditions. Each measurement was repeated three times, and the
final result was the average of the three independent scans.
Fluorescence Spectra of Wild-type hLGK2 and hLGK2
Mutant Proteins
Fluorescence experiments of hLGK2 WT and mutant hLGK2
proteins K169A were carried out on a Hitachi F-2500 fluorescence
spectrophotometer. The samples were prepared in 20 mM
NaH2PO4 solution at pH 7.1 with protein concentration at
5 mM. The fluorescence emission spectra from 300 to 400 were
collected after excitation at 280 nm. Fluorescence emission spectra
of proteins were determined using a 1 cm path quartz cuvette at
25uC. The spectral band width was 5 nm for excitation and 10 nm
for emission. The maximal emission wavelength was calculated by
the affiliated software of the F-2500 spectrophotometer.
Supporting Information
Table S1 Hydrogen bonds existing in the GMAG complex
model and their occupancies in the 10-ns MD simulation.
Found at: doi:10.1371/journal.pone.0006304.s001 (0.05 MB
DOC)
Table S2 Predicted binding free energies of GK and GKK169A
mutant with glucose and ATP.
Found at: doi:10.1371/journal.pone.0006304.s002 (0.03 MB
DOC)
Figure S1 Comparison between GK and homology hexokinases
I. (A) The sequence alignment of GK and hexokinases I. (B) Local
conformation of residues around ATP binding pocket in the
superimposed crystal structures 1DGK(hexokinases I), 1HKC
(hexokinases I) and 1V4S(GK). The ATP is colored by cyan. The
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and green, respectively.
Found at: doi:10.1371/journal.pone.0006304.s003 (4.35 MB TIF)
Figure S2 Time dependencies of the weighted Root-Mean-
Square Deviations (wRMSDs) for the atoms of glucose (A), ATP
(B) and GK (C) from their initial positions during the 10-ns MD
simulation. (D) Residue fluctuations obtained by averaging atomic
fluctuations over the MD simulation (black curve) and by
computing the value from experimentally derived B factors (red
curve) for GK crystal structure. (E) Time dependencies of energy
during the 10-ns MD simulation.
Found at: doi:10.1371/journal.pone.0006304.s004 (1.89 MB TIF)
Figure S3 SDS-PAGE for the purified wild-type hLGK2 and its
K169A mutant proteins (M: Marker; WT: wild-type hLGK2;
K169A: hLGK2 K169A mutant). The molecular weight of wild-
type hLGK2 and hLGK2 K169 mutant proteins were evaluated
as about 52 kDa indicating by the standard protein markers,
which is in agreement with the calculated mass (52 kDa).
Found at: doi:10.1371/journal.pone.0006304.s005 (8.41 MB TIF)
Figure S4 CD spectra of recombinant wild-type hLGK2 and
K169A mutant proteins. Far-UV CD spectra of recombinant
proteins were monitored at the concentration of 5 mM/L in
20 mM NaH2PO4 buffer (pH 7.1).
Found at: doi:10.1371/journal.pone.0006304.s006 (0.66 MB TIF)
Figure S5 Fluorescence emission spectra of recombinant hLGK2
(wild-type) and K169A mutant proteins. Fluorescence emission
spectra of the recombinant proteins were monitored at the
concentration of 5 mM/L in 20 mM NaH2PO4 buffer (pH 7.1).
Found at: doi:10.1371/journal.pone.0006304.s007 (4.27 MB TIF)
Figure S6 The partitioning scheme of QM and MM regions for
the GMAG complex in the QM/MM calculations. Atoms in the
QM region are displayed in ball and stick. ATP, Mg
2+, glucose
and important residues in GK are labeled.
Found at: doi:10.1371/journal.pone.0006304.s008 (4.45 MB TIF)
Figure S7 A close view of the configuration of K169N in the
environment of GK active site.
Found at: doi:10.1371/journal.pone.0006304.s009 (0.62 MB TIF)
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